Clinical Trial

Measuring Aided Language Development

Study acronym: MALD
Recruiting
View on ClinicalTrials.gov →
Summary
The focus of the current study is to systematically investigate the psychometric properties of a range of aided language measures, which are based on the Graphic Symbol Utterance and Sentence Development Framework (Binger \& Kent-Walsh).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-16; most recent amendment 2025-05-13.
Status change: Not Yet Recruiting → Recruiting 2025-04-28
Trial Details
NCT Number NCT06512168
Lead Sponsor University of Central Florida
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD), University of New Mexico, University of Wisconsin, Milwaukee
Conditions Down Syndrome, Cerebral Palsy, Apraxia of Speech, Speech Sound Disorder, Speech Disorders in Children, Speech and Language Disorder
Enrollment 60 participants
Start Date 2025-04-01
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-16